Exact Mass: 465.1734
Exact Mass Matches: 465.1734
Found 216 metabolites which its exact mass value is equals to given mass value 465.1734
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cisapride
In many countries (including Canada) cisapride has been either withdrawn or has had its indications limited due to reports about long QT syndrome due to cisapride, which predisposes to arrhythmias. The FDA issued a warning letter regarding this risk to health care professionals and patients. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].
cisapride
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].
(E)-Squamosamide
(E)-Squamosamide is found in fruits. (E)-Squamosamide is isolated from branches of Annona squamosa (sugar apple). Isolated from branches of Annona squamosa (sugar apple). (E)-Squamosamide is found in fruits.
(Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide
Squamosamide
Trelanserin
Ala Cys Ser Trp
Ala Cys Trp Ser
Ala Met Met Asn
Ala Met Asn Met
Ala Asn Met Met
Ala Ser Cys Trp
Ala Ser Trp Cys
Ala Trp Cys Ser
Ala Trp Ser Cys
Cys Ala Ser Trp
Cys Ala Trp Ser
Cys Cys Ile Gln
Cys Cys Leu Gln
Cys Cys Gln Ile
Cys Cys Gln Leu
Cys Gly Met Arg
Cys Gly Arg Met
Cys Gly Thr Trp
Cys Gly Trp Thr
Cys Ile Cys Gln
Cys Ile Gln Cys
Cys Leu Cys Gln
Cys Leu Gln Cys
Cys Met Gly Arg
Cys Met Asn Val
Cys Met Arg Gly
Cys Met Val Asn
Cys Asn Met Val
Cys Asn Val Met
Cys Gln Cys Ile
Cys Gln Cys Leu
Cys Gln Ile Cys
Cys Gln Leu Cys
Cys Arg Gly Met
Cys Arg Met Gly
Cys Ser Ala Trp
Cys Ser Trp Ala
Cys Thr Gly Trp
Cys Thr Trp Gly
Cys Val Met Asn
Cys Val Asn Met
Cys Trp Ala Ser
Cys Trp Gly Thr
Cys Trp Ser Ala
Cys Trp Thr Gly
Gly Cys Met Arg
Gly Cys Arg Met
Gly Cys Thr Trp
Gly Cys Trp Thr
Gly Met Cys Arg
Gly Met Met Gln
Gly Met Gln Met
Gly Met Arg Cys
Gly Gln Met Met
Gly Arg Cys Met
Gly Arg Met Cys
Gly Thr Cys Trp
Gly Thr Trp Cys
Gly Trp Cys Thr
Gly Trp Thr Cys
Ile Cys Cys Gln
Ile Cys Gln Cys
Ile Gln Cys Cys
Leu Cys Cys Gln
Leu Cys Gln Cys
Leu Gln Cys Cys
Met Ala Met Asn
Met Ala Asn Met
Met Cys Gly Arg
Met Cys Asn Val
Met Cys Arg Gly
Met Cys Val Asn
Met Gly Cys Arg
Met Gly Met Gln
Met Gly Gln Met
Met Gly Arg Cys
Met Met Ala Asn
Met Met Gly Gln
Met Met Asn Ala
Met Met Gln Gly
Met Asn Ala Met
Met Asn Cys Val
Met Asn Met Ala
Met Asn Val Cys
Met Gln Gly Met
Met Gln Met Gly
Met Arg Cys Gly
Met Arg Gly Cys
Met Val Cys Asn
Met Val Asn Cys
Asn Ala Met Met
Asn Cys Met Val
Asn Cys Val Met
Asn Met Ala Met
Asn Met Cys Val
Asn Met Met Ala
Asn Met Val Cys
Asn Val Cys Met
Asn Val Met Cys
Gln Cys Cys Ile
Gln Cys Cys Leu
Gln Cys Ile Cys
Gln Cys Leu Cys
Gln Gly Met Met
Gln Ile Cys Cys
Gln Leu Cys Cys
Gln Met Gly Met
Gln Met Met Gly
Arg Cys Gly Met
Arg Cys Met Gly
Arg Gly Cys Met
Arg Gly Met Cys
Arg Met Cys Gly
Arg Met Gly Cys
Ser Ala Cys Trp
Ser Ala Trp Cys
Ser Cys Ala Trp
Ser Cys Trp Ala
Ser Trp Ala Cys
Ser Trp Cys Ala
Thr Cys Gly Trp
Thr Cys Trp Gly
Thr Gly Cys Trp
Thr Gly Trp Cys
Thr Trp Cys Gly
Thr Trp Gly Cys
Val Cys Met Asn
Val Cys Asn Met
Val Met Cys Asn
Val Met Asn Cys
Val Asn Cys Met
Val Asn Met Cys
Trp Ala Cys Ser
Trp Ala Ser Cys
Trp Cys Ala Ser
Trp Cys Gly Thr
Trp Cys Ser Ala
Trp Cys Thr Gly
Trp Gly Cys Thr
Trp Gly Thr Cys
Trp Ser Ala Cys
Trp Ser Cys Ala
Trp Thr Cys Gly
Trp Thr Gly Cys
Sulprostone
G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AD - Prostaglandins D012102 - Reproductive Control Agents > D008600 - Menstruation-Inducing Agents D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents C78568 - Prostaglandin Analogue
Squamosamide
2-(4-Methoxybenzylidene)imino-2-deoxy-1,3,4,6-Tetra-O-acetyl-beta-D-glucopyranose
4-{4-[(3,5-Dimethyl-1,2-oxazol-4-yl)carbonyl]-1-piperazinyl}-N,N- diethyl-3-nitrobenzenesulfonamide
3-FLUORO-5-METHOXY-N-(2-(3-(PIPERAZIN-1-YLMETHYL)IMIDAZO[2,1-B]THIAZOL-6-YL)PHENYL)BENZAMIDE
Haloperidol Lactate
C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
Bevonium metilsulfate
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
2-[(4-methyl-3-phenyl-3H-1,5-benzodiazepin-2-yl)amino]-2-oxoethyl 4-methylpiperazine-1-carbodithioate
(2R)-1-(Dimethylamino)-3-{4-[(6-{[2-fluoro-5-(trifluoromethyl)phenyl]amino}pyrimidin-4-YL)amino]phenoxy}propan-2-OL
[[(E)-5-[(1S,2S,8aR)-2-hydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enoxy]-oxidophosphoryl] phosphate
Brasiliquinone A
A carbopolycyclic compound that is (3S)-3-ethyl-6,8-dihydroxy-3,4-dihydrotetraphene-1,7,12(2H)-trione substituted at position 8 by a 3-amino-2,3,6-trideoxy-alpha-L-ribo-hexopyranosyl group. It is isolated from the culture broth of Nocardia brasiliensis and exhibits antibacterial activity against Gram-positive bacteria. It is also active against the multiple drug-resistant P388/ADR tumour cells.
2-[6,7-dimethoxy-3-(3-methoxyphenyl)-2,4-dioxo-1-quinazolinyl]-N-(5-methyl-1H-pyrazol-3-yl)acetamide
4-[[3-Methoxy-4-[(4-nitrophenyl)methoxy]phenyl]-(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-5-methyl-1,2-dihydropyrazol-3-one
N-[(4-fluorophenyl)methyl]-2-[[4-(4-methoxyphenyl)-5-[(1-methyl-2-pyrrolyl)methyl]-1,2,4-triazol-3-yl]thio]acetamide
N-[4-[[anilino(sulfanylidene)methyl]amino]-2,5-diethoxyphenyl]-4-methoxybenzamide
(2E)-5-[(1S,2S,4aR,8aR)-2-hydroxy-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl diphosphate
(2E)-5-[(1R,2R,4aS,8aS)-1-hydroxy-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl diphosphate
4-fluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
4-fluoro-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
[(1S)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-cyclopropylmethanone
[(1R)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-cyclopropylmethanone
4-fluoro-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
4-fluoro-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
1-[2-[(2R,5R,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2S,5S,6R)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
4-fluoro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide
4-fluoro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
4-fluoro-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide
1-[2-[(2S,5R,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2R,5R,6R)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2S,5S,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2R,5S,6S)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[2-[(2S,5R,6R)-5-[[(3-chloroanilino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-3-(3,5-dimethyl-4-isoxazolyl)urea
Propulsid
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Cisapride (R 51619) is an orally active 5-HT4 receptor agonist with an EC50 value of 140 nM. Cisapride is a hERG blocker with an IC50 value of 9.4 nM. Cisapride is a gastroprokinetic agent that stimulates gastrointestinal motor activity[1][2][3][4].